Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality, pricey and fading Quality Strong, Valuation Expensive, Momentum Bearish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #45 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 1 Nov 2023 | VALUEQUEST INVESTMENT ADVISORS PRIVATE LIMITED | Bulk | Buy | 1,137,541 | 388.0000 | NSE |
| 1 Nov 2023 | NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL | Bulk | Buy | 2,100,000 | 380.0000 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| — | Final Dividend - Rs. - 1.2000 | — | — |
| 11 Sep 2026 | Dividend - Rs 1.20 Per Share | 1.2000 | 14 Sep 2026 |
| 19 Sep 2025 | Dividend - Rs 1.20 Per Share | 1.2000 | 19 Sep 2025 |
| 17 Sep 2024 | Dividend - Re 1 Per Share | 1.0000 | 18 Sep 2024 |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 17 Sep 2024 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 3 Aug 2026 | Financial Results | Yes |
| 25 May 2026 | Financial Results/Dividend/Fund Raising | Yes |
| 13 Feb 2026 | Financial Results | Yes |
| 4 Nov 2025 | Financial Results | Yes |
| 22 Jul 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
Part of: NIFTY 500
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
